BLOG

Tuesday, February 25, 2020

USFDA issues warning letter to Cipla for Goa manufacturing facility

The company further said that it remains committed to maintain highest standards of compliance and will work closely with the agency to comprehensively address all the observations

from Companies https://ift.tt/2w5Oay2
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...